| | Kinase Inhibitors
- 1-(5-Isoquinolinesulfonyl)-3-methylpiperazine, hydrochloride
A selective inhibitor of protein kinase C or cyclic-nucleotide-dependent protein kinases.| Catalog # | CAS Number | Molecular Formula | Unit |
|---|
| sc-213276 | 141543-65-9 | C14H17N3O2S•HCl | 25 mg |
- 1-(5-Isoquinolinesulfonyl)piperazine Hydrochloride
Exhibits potent inhibition toward protein kinase C and cyclic nucleotide dependent protein kinases.| Catalog # | CAS Number | Molecular Formula | Unit |
|---|
| sc-213277 | 141543-63-7 | C13H16ClN3O2S | 25 mg |
- 1-(5-Isoquinolinylsulfonyl)-3-methylpiperazine dihydrochloride
A lesser potent inhibitor of phosphokinase C than H-7.| Catalog # | CAS Number | Molecular Formula | Unit |
|---|
| sc-213278 | 140663-38-3 | C14H19Cl2N3O2S | 5 mg/25 mg |
- 1-Naphthyl PP1
A kinase inhibitor that inhibits src family kinses v-Src, c-Fyn, and the proto-oncogene c-Abl.| Catalog # | CAS Number | Molecular Formula | Unit |
|---|
| sc-203765 | 221243-82-9 | C19H19N5 | 10 mg/50 mg |
- 1,2,3,4-Tetrahydro Staurosporine
Staurosporine derivative used as an isoenzyme PKCå inhibitor and as an anticancer agent.| Catalog # | CAS Number | Molecular Formula | Unit |
|---|
| sc-206233 | 220038-19-7 | C28H30N4O3 | 500 µg |
- 1,3-Bis-(o-tert-butyldimethylsilyl)-Fmoc-D-erythro-sphingosine
Protected Sphingosine.| Catalog # | CAS Number | Molecular Formula | Unit |
|---|
| sc-213489 | N/A | C45H75NO4Si2 | 25 mg |
- 2-Aminopurine Dihydrochloride
A purine analog that acts as a protein kinase inhibitor. It acts as a mutagen, can override checkpoints of the cell cycle and induce S-phase arrested cells to enter mitosis incorrectly. | Catalog # | CAS Number | Molecular Formula | Unit |
|---|
| sc-201524 | 76124-64-6 | C5H5N5•2HCl | 100 mg/500 mg |
- 2-Azido-1-pivaloyl-D-erythro-Sphingosine
A derivative of Sphingosine. A selective inhibitor of protein kinase C activity and phorbol dibutyrate binding in vitro in human platelets. Also inhibits calmodulin-dependent enzymes.| Catalog # | CAS Number | Molecular Formula | Unit |
|---|
| sc-206402 | 114275-41-1 | C23H43N3O3 | 20 mg |
- 2-Bromoaldisine
Inhibitor of the Raf/MEK-1/MAPK cascade (IC50= 539nM).| Catalog # | CAS Number | Molecular Formula | Unit |
|---|
| sc-202880 | 96562-96-8 | C8H7BrN2O2 | 0.5 mg |
- 2,3,6-Trideoxy-Ins(1,4,5)P3. 6Na
Exhibits relatively low ligand binding affinity to the Ins(1,4,5)P3 receptor of bovine adrenal cortex membranes and acts as a weak agonist in releasing calcium from saponin permeablized SH-Sy5Y human neurolastoma cells.| Catalog # | CAS Number | Molecular Formula | Unit |
|---|
| sc-220787 | N/A | N/A | 1 mg |
- (2S,3R,4E)-2-Azido-3-(tert-butyldimethylsilyl)-1-pivaloyl-erythro-sphingosine
A derivative of Sphingosine. Selective inhibitor of protein kinase C activity and phorbol dibutyrate binding in vitro in human platelets. Inhibits calmodulin-dependent enzymes.| Catalog # | CAS Number | Molecular Formula | Unit |
|---|
| sc-206567 | 114275-42-2 | C29H57N3O3Si | 20 mg |
- (2S,3R,4E)-2-Azido-3-(tert-butyldimethylsilyl)-erythro-sphingosine
A derivative of Sphingosine, a selective inhibitor of protein kinase C activity and phorbol dibutyrate binding in vitro in human platelets. Also inhibits calmodulin-dependent enzymes.| Catalog # | CAS Number | Molecular Formula | Unit |
|---|
| sc-206568 | 114299-64-8 | C24H49N3O2Si | 10 mg |
- 3-O-(tert-Butyldimethylsilyloxy)-2-Fmoc-erythro-sphingosine
A derivative of Sphingosine that is a selective inhibitor of protein kinase C activity and phorbol dibutyrate binding in vitro in human platelets. This compound does not inhibit protein kinase A or myosin light chain kinase, but does inhibit calmodulin-dependent enzymes.| Catalog # | CAS Number | Molecular Formula | Unit |
|---|
| sc-206670 | 149035-77-8 | C39H61NO4Si | 10 mg |
- 3-O-(tert-Butyldimethylsilyloxy)-erythro-sphingosine
This derivative of Sphingosine is a selective inhibitor of protein kinase C activity and phorbol dibutyrate binding in vitro in human platelets. This compound does not inhibit protein kinase A or myosin light chain kinase, although it inhibits calmodulin-dependent enzymes.| Catalog # | CAS Number | Molecular Formula | Unit |
|---|
| sc-206671 | 137905-29-4 | C24H51NO2Si | 10 mg |
- 3,4-Dihydro-2H,10H-azepino[3,4-b]indole-1,5-dione Methanesulfonate Salt
A myt1 kinase inhibitor used in the treatment of proliferative diseases| Catalog # | CAS Number | Molecular Formula | Unit |
|---|
| sc-206703 | 68724-84-5 | C13H14N2O5S | 5 mg |
- 4-Amino-1-tert-butyl-3-(3-methylbenzyl)pyrazolo[3,4-d]pyrimidine
A highly potent and uniquely specific tyrosine kinase inhibitor of v-Src tyrosine kinase.| Catalog # | CAS Number | Molecular Formula | Unit |
|---|
| sc-206805 | 956025-83-5 | C17H21N5 | 10 mg |
- 5-(5,6-dimethoxy-1H-benzimidazol-1-yl)-3-[[4-(methylsulfonyl)phenyl]methoxy]-2-thiophenecarboxamide
A potent benzimidazole analog that inhibits IKK-ε with an IC50 value of ~15.8 µM, where IKK-ε is mostly expressed n immune cells and thought to play a role in immune response.| Catalog # | CAS Number | Molecular Formula | Unit |
|---|
| sc-205128 | 916985-21-2 | C22H21N3O6S2 | 1 mg/5 mg |
- 5-Iodo-Indirubin-3'-monoxime
A highly potent of glycogen synthase kinase-3β inhibitor. Also inhibits Cdk1 and Cdk5 activities. Acts by binding to the ATP-binding pocket of these enzymes. | Catalog # | CAS Number | Molecular Formula | Unit |
|---|
| sc-221754 | N/A | C16H10IN3O2 | 1 mg |
- 5'-Tosyl Thymidine
A nucleoside analogue used as inhibitors of thymidylate kinases| Catalog # | CAS Number | Molecular Formula | Unit |
|---|
| sc-207074 | 7253-19-2 | C17H20N2O7S | 250 mg |
- 7-Azaoxindole
Used for preparation of 3-(anilinomethylene) oxindoles and analogs as protein tyrosine kinase and protein serine/threonine kinase inhibitors.| Catalog # | CAS Number | Molecular Formula | Unit |
|---|
| sc-207155 | 5654-97-7 | C7H6N2O | 100 mg |
- 7,8-Dihydro-9-[2-(4-bromophenyl)hydrazone]-5H-pyrido[3,2-b]azepine-6,9-dione
A GSK-3 inhibitor used | Catalog # | CAS Number | Molecular Formula | Unit |
|---|
| sc-207184 | 676596-64-8 | C15H13BrN4O | 10 mg |
- A 419259 trihydrochloride
| Catalog # | CAS Number | Molecular Formula | Unit |
|---|
| sc-361094 | 364042-47-7 | C29H34N6O•3HCl | 10 mg |
- A 83-01
Selective inhibitor of TGF-β type I receptor ALK5 kinase, type I activin/nodal receptor ALK4 and type I nodal receptor ALK7 (IC50 values are 12, 45 and 7.5 nM respectively). Blocks phosphorylation of Smad2 and inhibits TGF-β-induced epithelial-to-mesenchymal transition. Only weakly inhibits ALK-1, -2, -3, -6 and MAPK activity. More potent than SB 431542. | Catalog # | CAS Number | Molecular Formula | Unit |
|---|
| sc-203791 | 909910-43-6 | C25H19N5S | 10 mg/50 mg |
- AAL-993
A highly potent inhibitor of VEGFR-1, VEGFR-2 and VEGFR-3 (IC50=130nM, IC50=23nM and IC50=18nM respectively). At higher concentrations it inhibits PDGFR-β (640nM), c-Kit (236nM) and CSF-1R (380nM).| Catalog # | CAS Number | Molecular Formula | Unit |
|---|
| sc-221195 | 269390-77-4 | C20H16N3OF3 | 5 mg/25 mg |
- Adenosine Kinase Inhibitor
Cell-permeable. Acts as a potent, adenosine-competitive, and reversible adenosine kinase (AK) inhibitor.| Catalog # | CAS Number | Molecular Formula | Unit |
|---|
| sc-202900 | 214697-26-4 | C22H19BrN6O•2HCl•xH2O | 5 mg |
- Adaphostin
A p210bcr/abl tyrosine kinase inhibitor (IC50 = 14 μM). Induces apoptosis in T-lymphoblastic human leukemia cell lines (IC50 values range from 16.8 to 216.3 nM) in vitro. Has been shown to display selectivity for chronic myelogenous leukemia (CML) myeloid progenitors in vitro. | Catalog # | CAS Number | Molecular Formula | Unit |
|---|
| sc-291833 | 241127-58-2 | C24H27NO4 | 10 mg/50 mg |
- AEG 3482
Cell-permeable imidazothiadiazole compound that activates HSF1 by binding to HSP90 and disrupting its association with HSF1.| Catalog # | CAS Number | Molecular Formula | Unit |
|---|
| sc-202911 | 63735-71-7 | C10H8N4O2S2 | 5 mg |
- (+)-Aeroplysinin-1
Displays cytostatic and cytotoxic activity. Inhibitor of EGFR kinase. Shows antiangiogenic activity.| Catalog # | CAS Number | Molecular Formula | Unit |
|---|
| sc-202445 | 28656-91-9 | C9H9Br2NO3 | 1 mg |
- AG 43
An inactive tyrphostin analogue that can be used a negative control parameter for other tyrphostins.| Catalog # | CAS Number | Molecular Formula | Unit |
|---|
| sc-202916 | 5553-97-9 | C10H8N2O | 5 mg |
- AG 556
Selectively inhibits EGF receptor kinase autophosphorylation (IC50 = 5 µM) over HER1/2 autophosphorylation. Also blocks LPS-induced TNF-α production.| Catalog # | CAS Number | Molecular Formula | Unit |
|---|
| sc-202044 | 133550-41-1 | C20H20N2O3 | 5 mg/25 mg |
- AG-1296
A potent inhibitor of PDGF receptor tyrosine kinase (IC50=1 µM). Inhibits FGF receptor tyrosine kinase and c-kit. | Catalog # | CAS Number | Molecular Formula | Unit |
|---|
| sc-200631 | 146535-11-7 | C16H14N2O2 | 5 mg/25 mg |
- AG-490
A tyrosine kinase inhibitor that belongs to the family of tyrphostins. Compound has been reported to inhibit JAK2 and not JAK1, Lck, Btk, Tyk2, Syk, Lyn, and Src.| Catalog # | CAS Number | Molecular Formula | Unit |
|---|
| sc-202046 | 134036-52-5 | C17H14N2O3 | 10 mg/50 mg |
- Akt Inhibitor
A phosphatidylinositol ether analog that potently and selectively inhibits Akt (PKB) (IC50 of 5.0 µM). Moderately inhibits PI 3-K activity (IC50 = 83.0 µM). Also inhibits the growth of various cancer cell lines with IC50 values in the 1 - 10 µM range. | Catalog # | CAS Number | Molecular Formula | Unit |
|---|
| sc-221226 | N/A | C30H58O10 | 1 mg |
- Akt Inhibitor III
A phosphatidylinositol analog that inhibits the activation of Akt and select downstream substrates without decreasing phosphorylation of PDK-1 or other kinases downstream of Ras, such as MAPK.| Catalog # | CAS Number | Molecular Formula | Unit |
|---|
| sc-221228 | N/A | C28H57O9P | 1 mg |
- Akt Inhibitor IV
Inhibitor of Akt protein kinase and reported to inhibit the ATP-binding site of kinase upstream of AKT and downstream of PI3K. | Catalog # | CAS Number | Molecular Formula | Unit |
|---|
| sc-203809 | 681281-88-9 | C31H27IN4S | 1 mg/5 mg |
- Akt Inhibitor IX, API-59CJ-OMe
A cell-permeable ellipticine compound that selectively and potently induces apoptosis in human endometrial cancer cells (RL95-2 and Ishikawa) that exhibit elevated Akt activity (effective concentration = 12-24 µM), but not on cells with low Akt activity.| Catalog # | CAS Number | Molecular Formula | Unit |
|---|
| sc-203810 | 98510-80-6 | C21H22N2O3 ·3H2O | 5 mg |
- Akt Inhibitor X
A cell permeable, reversible, and selective inhibitory phenoxazine that suppresses the kinase reactivity of Akt by inhibiting its phosphorylation.| Catalog # | CAS Number | Molecular Formula | Unit |
|---|
| sc-203811 | 925681-41-0 | C20H25ClN2O ·HCl | 5 mg |
- Akt Inhibitor XI
A cell-permeable copper complex that interacts with both the PH and the kinase domains of Akt and potently inhibits its kinase activity. Inhibits tumor growth both in cultured cells in vitro and in mice in vivo without any apparent adverse effect to the animals.
| Catalog # | CAS Number | Molecular Formula | Unit |
|---|
| sc-221229 | N/A | C11H9Cl2CuN3O2S | 5 mg |
- Akt Inhibitor XII, Isozyme-Selective, Akti-2
A cell-permeable Akti-1/2- (sc-202048) derived allosteric inhibitor pair (1:1 regioisomeric mixture) with much improved aqueous solubility (10 mg/ml in a pH 7.4 saline) and Akt2 selectivity (IC50 = 805 nM for Akt2, >10 µM for Akt1/3, and >50 µM for PKA/PKC/SGK). The inhibition is PH domain-dependent and non-competitive with ATP.| Catalog # | CAS Number | Molecular Formula | Unit |
|---|
| sc-221230 | N/A | C39H39N7O2 ·3HCl | 2 mg |
- Akt Inhibitor XIII, Isozyme-Selective, Akti2-1/2
A highly cell-permeable and water soluble analog of Akt Inhibitor VIII, Isozyme-Selective, Akti-1/2 (sc-202048) that acts as a plecktrin homology (PH)-domain dependent, non-ATP competitive and an allosteric inhibitor of Akt1/2 (IC50 = 560 nM, 390 nM and 7.8 µM in in vitro kinase assay; 526 nM, 730 nM and > 10 µM in LNCaP cells for Akt1, Akt2 and Akt3, respectively) with ~ 80-fold greater selectivity over PKA, PKC and SGK (IC550> 50 µM). One of its potent regioisomers (C7-substituted) is shown to enhance induced caspase-3 activity in several tumor cells. | Catalog # | CAS Number | Molecular Formula | Unit |
|---|
| sc-221231 | N/A | C40H43N7O2 ·3HCl | 2 mg |
- AP 24534
| Catalog # | CAS Number | Molecular Formula | Unit |
|---|
| sc-362710 | 943319-70-8 | C29H27F3N6O | 10 mg/50 mg |
- Apigenin
Inhibits MAP kinase-associated signal transduction pathways and proliferation of malignant tumor cells by causing G2/M arrest and induces morphological differentiation.| Catalog # | CAS Number | Molecular Formula | Unit |
|---|
| sc-3529 | 520-36-5 | C15H10O5 | 5 mg/100 mg |
- AS-604850
This is a potent, cell permeable and ATP-competitive inhibitor of phosphoinositide 3-kinase γ (PI(3)Kγ). it exhibits selectivity over other PI(3)K isoforms.| Catalog # | CAS Number | Molecular Formula | Unit |
|---|
| sc-221271 | 648449-76-7 | C11H5F2NO4S | 1 mg/5 mg |
- AS-605240
This is a potent, cell permeable and ATP-competitive inhibitor of phosphoinositide 3-kinase γ (PI(3)Kγ). It exhibits selectivity over other PI(3)K isoforms.| Catalog # | CAS Number | Molecular Formula | Unit |
|---|
| sc-221272 | 648450-29-7 | C12H7N3O2S | 1 mg/5 mg |
- ATM Kinase Inhibitor
A cell-permeable, potent, selective and ATP-competitive inhibitor of ATM (Ataxia telangiectasia mutated). Shows inhibition specificity for other phosphatidylinositol 3'-kinase-like kinases.| Catalog # | CAS Number | Molecular Formula | Unit |
|---|
| sc-202963 | 587871-26-9 | C21H17NO3S2 | 2 mg |
- ATM/ATR Kinase Inhibitor
| Catalog # | CAS Number | Molecular Formula | Unit |
|---|
| sc-202964 | 905973-89-9 | C23H18Cl3FN4O3S | 5 mg |
- Aurora Kinase Inhibitor II
Aurora Kinase Inhibitor II is an anilinoquinazoline that is both a potent and selective ATP-competitive inhibitor of Aurora kinases and has the ability to permeate the cell. | Catalog # | CAS Number | Molecular Formula | Unit |
|---|
| sc-203827 | 331770-21-9 | C23H20N4O3 | 1 mg |
- Aurora Kinase Inhibitor III
A cell-permeable 2,4-dianilinopyrimidine compound that acts as an ATP-competitive, potent, but non-selective inhibitor of Aurora A (IC50 = 42 nM). At higher concentrations, inhibits the activities of other kinases, such as Lck, Bmx, IGF-1R, and Syk as well(IC50 = 131, 386, 591, and 887 nM, respectively). | Catalog # | CAS Number | Molecular Formula | Unit |
|---|
| sc-203828 | 879127-16-9 | C21H18F3N5O | 1 mg |
- Avenanthramide-C methyl ester
Avenanthramide-C methyl ester inhibits NF-κB activation by blocking the phosphorylation of IKK and IκB (IC50 ~ 40 μM). Through this mechanism, avenanthramide-C methyl ester dose dependently inhibits the secretion and expression of IL-6, IL-8, and MCP-1 in human aortic endothelial cells.| Catalog # | CAS Number | Molecular Formula | Unit |
|---|
| sc-223786 | 955382-52-2 | C17H15NO6 | 500 µg/1 mg |
- AZ 3146
| Catalog # | CAS Number | Molecular Formula | Unit |
|---|
| sc-361114 | 1124329-14-1 | C24H32N6O3 | 10 mg/50 mg |
- Azido-erythro-sphingosine
A derivative of Sphingosine. A selective inhibitor of protein kinase C activity and phorbol dibutyrate binding in vitro in human platelets. Also inhibits calmodulin-dependent enzymes.| Catalog # | CAS Number | Molecular Formula | Unit |
|---|
| sc-207312 | 103348-49-8 | C18H35N3O2 | 25 mg |
- BAY R3401
A glycogen phosphorylase inhibitor shown to suppress hepatic glycogenolysis.| Catalog # | CAS Number | Molecular Formula | Unit |
|---|
| sc-239281 | 100276-03-7 | C20H22ClNO4 | 5 mg |
- BC 11 hydrobromide
| Catalog # | CAS Number | Molecular Formula | Unit |
|---|
| sc-362712 | 443776-49-6 | C8H11BN2O2S.HBr | 10 mg/50 mg |
- Bcr-abl Inhibitor II
A cell-permeable thiadiazole compound that acts as an ATP binding site-targeting inhibitor of Abl and c-Src kinases (Ki = 44 and 354 nM, respectively). Effectively inhibits cellular Bcr-Abl Tyr245 phosphorylation and the clonogenic activity of Bcr-Abl-transformed 32D cells, regardless of their resistance to Imatinib/STI571.| Catalog # | CAS Number | Molecular Formula | Unit |
|---|
| sc-221289 | N/A | C16H11F2N3OS2 | 5 mg |
- BI 78D3
Competitive c-Jun N-terminal kinase (JNK) inhibitor (IC50 = 280 nM) that displays > 100 fold selectivity over p38α and no activity at mTOR and PI-3K. Inhibits JNK interacting protein 1 (JIP1)-JNK binding (IC50 = 500 nM) and prevents JNK substrate phosphorylation. Restores insulin sensitivity in a mouse model of type II diabetes and blocks JNK-dependent Con A-induced liver damage.| Catalog # | CAS Number | Molecular Formula | Unit |
|---|
| sc-203840 | 883065-90-5 | C13H9N5O5S2 | 10 mg/50 mg |
- BIO-acetoxime
| Catalog # | CAS Number | Molecular Formula | Unit |
|---|
| sc-361122 | 667463-85-6 | C18H12BrN3O3 | 1 mg/10 mg |
- Bisindolylmaleimide V
Negative control for the protein kinase C (PKC)-inhibitory activity.| Catalog # | CAS Number | Molecular Formula | Unit |
|---|
| sc-202080 | 113963-68-1 | C21H15N3O2 | 1 mg/5 mg |
- BML-257
BML-257 is an potent inhibitor of AKT1 translocation and has been observed to attenuate cannabinoid agonist-simulated neurosphere proliferation.| Catalog # | CAS Number | Molecular Formula | Unit |
|---|
| sc-200666 | 32387-96-5 | C21H14N2O2 | 10 mg/50 mg |
- BML-275
A cell-permeable pyrazolopyrimidine derivative that inhibits AMP Kinase in an ATP-competitive manner. Also inhibits morphogenetic protein signals.| Catalog # | CAS Number | Molecular Formula | Unit |
|---|
| sc-200689 | 866405-64-3 | C24H25N5O | 5 mg/25 mg |
- βARK1 Inhibitor
A selective inhibitor of βARK1 (β-Adrenergic Receptor Kinase 1). Has no inhibitory activity against protein kinase A (PKA). | Catalog # | CAS Number | Molecular Formula | Unit |
|---|
| sc-221268 | N/A | C12H9NO6 | 5 mg |
- BRD 7389
| Catalog # | CAS Number | Molecular Formula | Unit |
|---|
| sc-361129 | 376382-11-5 | C24H18N2O2 | 10 mg/50 mg |
- BTO-1
A cell-permeable benzothiazolo-N-oxide compound that targets the ATP-binding pocket of polo-like kinase and is shown to inhibit Plk1 kinase activity in cell-free kinase assays.| Catalog # | CAS Number | Molecular Formula | Unit |
|---|
| sc-204206 | 40647-02-7 | C9H4N4O4S | 2 mg |
- CaMKP Inhibitor
Amino-naphthol sulfonic acid that acts as a competitive substrate inhibitor of Ca2+/CaMKP and the nuclear isoform CaMKP-N. Exhibits little activity against PP2B/CaN and PP2C| Catalog # | CAS Number | Molecular Formula | Unit |
|---|
| sc-203866 | 52789-62-5 | C10H8NNAO7S2 ·2H2O | 100 mg |
- Casein Kinase II Inhibitor III, TBCA
A cell-permeable tetrabrominated cinnamic acid compound that acts as an ATP-competitive and potent inhibitor of Casein Kinase II with greater selectivity than DMAT and TBB (sc-202830).| Catalog # | CAS Number | Molecular Formula | Unit |
|---|
| sc-203869 | 934358-00-6 | C9H4Br4O2 | 5 mg |
- CAY10622
| Catalog # | CAS Number | Molecular Formula | Unit |
|---|
| sc-358882 | 1038549-25-5 | C25H25N5O3 | 1 mg/5 mg |
- CAY10576
The NF-κB/Rel transcription factors, known to be involved in the pathogenesis of a variety of diseases and the regulation of pro-inflammatory cytokines, are present in the cytosol in an inactive state, complexed with inhibitory IκB proteins. NF-κB is activated upon degradation of IκB following IKK-α and IKK-β phosphorylation. IKK-ε, a homolog of IKKα and IKK-β, can also activate NF-κB. IKK-ε is expressed primarily in immune cells, and is thought to play a role in the immune response. CAY10576 is a benzimidazole analog that selectively inhibits IKK-ε with an IC50 value of 40 nM and is essentially inactive at IKK-α and IKK-β.1| Catalog # | CAS Number | Molecular Formula | Unit |
|---|
| sc-223870 | 862812-98-4 | C22H19N3O5S2 | 1 mg/5 mg |
- CCT 137690
| Catalog # | CAS Number | Molecular Formula | Unit |
|---|
| sc-362722 | 1095382-05-0 | C26H31BrN8O | 10 mg/50 mg |
- Cell Sheet Migration Inhibitor, Locostatin
A cell-permeable and potent inhibitor of Raf kinase inhibitor protein (RKIP)/Raf1 kinase interaction.| Catalog # | CAS Number | Molecular Formula | Unit |
|---|
| sc-203875 | 133812-16-5 | C14H15NO3 | 10 mg |
- Cell Sheet Migration Inhibitor, Negative Control
A cell-permeable N-(butyryl)oxazolidinone compound which serves as a negative control for the Cell Sheet Migration Inhibitor. Displays little bioactivity during wound closure and cell proliferation studies. | Catalog # | CAS Number | Molecular Formula | Unit |
|---|
| sc-221412 | N/A | C14H17NO3 | 5 mg |
- Ceramide Kinase Inhibitor, K1
A cell-permeable tetracyclic quinone compound that acts as a specific, reversible, and non-competitive inhibitor of CerK (ceramide kinase) activity with little effect against SPHK1/2 or DGK. Shown to reduce cellular C1P (ceramide-1-phosphate) synthesis by 40% at 20 µM in a rat basophilic leukemia cell line RBL-2H3 and block CerK-mediated degranulation in both RBL-2H3 and murine BMMC (bone marrow-derived mast cells) in a dose-dependent manner. Exhibits no cytotoxic effect against RBL-2H3 even at concentrations as high as 100 µM. | Catalog # | CAS Number | Molecular Formula | Unit |
|---|
| sc-221414 | 1258005-85-4 | C21H28O4 | 1 mg |
- CID 755673
A selective and potent protein kinase D1-D3, PKC, CAK, PLK1 and CAMKIIα inhibitor. Reported to inhibit PKD-mediated protein transport and to reverse phorsphorylation of Ser-82 on small heat shock protein 27 (HSP27) in a human neuroblastoma cell line.| Catalog # | CAS Number | Molecular Formula | Unit |
|---|
| sc-205246 | 521937-07-5 | C12H11NO3 | 10 mg |
- Compound 401
Cell-permeable pyrimido-isoquinolinone compound. Potent, reversible, and ATP-competitive inhibitor of DNA-PK with ~19-fold selectivity over mTOR. | Catalog # | CAS Number | Molecular Formula | Unit |
|---|
| sc-202552 | 168425-64-7 | C16H15N3O2 | 5 mg |
- Compound 56
The most potent and specific inhibitor of the tyrosine kinase activity of the epidermal growth factor receptor.| Catalog # | CAS Number | Molecular Formula | Unit |
|---|
| sc-203430 | 171745-13-4 | C18H18BrN3O2 | 500 µg |
- Cucurbitacin I, Cucumis sativus L.
Shown to be a Stat3 and JAK2 inhibitor. Also reported to contain in vitro anti-proliferative activity against certain cancer cells .| Catalog # | CAS Number | Molecular Formula | Unit |
|---|
| sc-203010 | 2222-07-3 | C30H42O7 | 1 mg |
- Cyclapolin 9
Selective, ATP-competitive polo-like kinase 1 (PLK1) inhibitor.| Catalog # | CAS Number | Molecular Formula | Unit |
|---|
| sc-205279 | 40533-25-3 | C9H4F3N3O4S | 10 mg/50 mg |
- DAG Kinase Inhibitor
DAG Kinase Inhibitor is an inhibitor of DGK (Diacylglycerol kinase; DAG Kinase) and is useful for elucidating the roles of protein kinase C (PKC). This particular isoform, R59949, has been reported to potentially exhibit selective inhibition of DGK-α. | Catalog # | CAS Number | Molecular Formula | Unit |
|---|
| sc-3551 | 120166-69-0 | C28H25F2N3OS | 5 mg |
- Debromohymenialdisine
Inhibitor of G2 DNA damage checkpoint (IC50=8µM),Chk1 (IC50=3µM) and Chk2 (IC50=3.5µM). DBH does not inhibit ATM or ATM-Rad3-related protein. | Catalog # | CAS Number | Molecular Formula | Unit |
|---|
| sc-202127 | 75593-17-8 | C11H11N5O2 | 100 µg |
- Dioctanoylglycol
Diacylglycerol kinase inhibitor.| Catalog # | CAS Number | Molecular Formula | Unit |
|---|
| sc-203567 | 627-86-1 | C18H34O4 | 50 mg |
- DMH-1
| Catalog # | CAS Number | Molecular Formula | Unit |
|---|
| sc-361171 | 1206711-16-1 | C24H20N4O | 10 mg/50 mg |
- DMNB
Cell-permeable vanillin derivative that acts as a potent and selective inhibitor of DNA-PK activity and DNA-PK-mediated DSB DNA repair by non-homologous DNA-end-joining (NHEJ).| Catalog # | CAS Number | Molecular Formula | Unit |
|---|
| sc-202142 | 20357-25-9 | C9H9NO5 | 10 mg |
- DNA-PK Inhibitor II
Shown to be a cell permeable potent antiproliferative agent. Reported to reduce lethal damage recovery in cells and DNA double strand break repair. | Catalog # | CAS Number | Molecular Formula | Unit |
|---|
| sc-202143 | 154447-35-5 | C17H15NO3 | 10 mg/50 mg |
- DNA-PK Inhibitor III
Cell-permeable, potent, selective, and an ATP-competitive inhibitor of DNA-PK and PI 3-Kinase catalytic subunit p110∫.| Catalog # | CAS Number | Molecular Formula | Unit |
|---|
| sc-203928 | 404009-40-1 | C12H15NO3 | 1 mg |
- DNA-PK Inhibitor IV
A morpholino-salicylaldehyde compound which acts as a potent, selective and ATP-competitive inhibitor of DNA-PK. Inhibits PI 3-K catalytic subunit p110-isozymes at higher concentrations and weakly inhibits a panel of several other kinases.| Catalog # | CAS Number | Molecular Formula | Unit |
|---|
| sc-221562 | N/A | C11H13NO3 | 1 mg |
- DNA-PK Inhibitor V
Potent, selective and ATP-competitive inhibitor of DNA-PK (IC50 = 270 nM); inhibits PI 3-K catalytic subunit p110-isozymes.| Catalog # | CAS Number | Molecular Formula | Unit |
|---|
| sc-203929 | 404009-46-7 | C17H17NO3 | 1 mg/5 mg |
- Dorsomorphin dihydrochloride
| Catalog # | CAS Number | Molecular Formula | Unit |
|---|
| sc-361173 | 866405-64-3 | C24H25N5O.2HCl | 10 mg/50 mg |
- DRB
Shown to be an adenosine analogue which causes a premature termination of DNA transcription. Also reported to be a mixed-type inhibitor of casein kinase II.| Catalog # | CAS Number | Molecular Formula | Unit |
|---|
| sc-200581 | 53-85-0 | C12H12Cl2N2O4 | 10 mg/50 mg |
- eEF-2 Kinase Inhibitor, NH125
Inhibits the activity of bacterial histidine kinases (EnvZ, PhoQ, BvgS, and EvgS) and eukaryotic eEF-2 kinase/CaMKIII.| Catalog # | CAS Number | Molecular Formula | Unit |
|---|
| sc-203037 | 278603-08-0 | C27H45IN2 | 5 mg |
- ER 27319 maleate
| Catalog # | CAS Number | Molecular Formula | Unit |
|---|
| sc-361177 | 201010-95-9 | C18H20N2O.C4H4O4 | 10 mg/50 mg |
- FAK Inhibitor 14
Selective FAK inhibitor that exhibits antiproliferative activity in a variety of human tumor cell lines in vivo, and promotes cell detachment/inhibits cell adhesion in vitro | Catalog # | CAS Number | Molecular Formula | Unit |
|---|
| sc-203950 | 4506-66-5 | C6H2(NH2)4 ·4HCl | 10 mg/50 mg |
- FCCP
Oxidative phosphorylation uncoupler in mitochondria.| Catalog # | CAS Number | Molecular Formula | Unit |
|---|
| sc-203578 | 370-86-5 | C10H5F3N4O | 10 mg/50 mg |
- FGF Receptor Tyrosine Kinase Inhibitor IV, NP603
A cell-permeable SU6668 derivative that targets the ATP-binding pocket and inhibits the kinase activity of PDGFRβ, FGFR1 and VEGFR2, while showing little activity against EGFR. Exhibits anti-angiogenesis activity and suppress FGF-2-induced proliferation in HUVEC cultures in a dose-dependent manner.
| Catalog # | CAS Number | Molecular Formula | Unit |
|---|
| sc-221613 | N/A | C26H26N2O5 | 5 mg |
- Flt-3 Inhibitor
Cell-permeable thienylcarboxamide that acts as a potent, ATP-competitive, and highly selective Flt-3 inhibitor.| Catalog # | CAS Number | Molecular Formula | Unit |
|---|
| sc-203048 | 301305-73-7 | C18H20N2O4S | 5 mg |
- Flt-3 Inhibitor II
A cell-permeable symmetrical indolylmethanone kinase inhibitor that is more selective to Flt3 over PDGFR; potently induces apoptosis in Flt3-expressing primary AML patient blasts.| Catalog # | CAS Number | Molecular Formula | Unit |
|---|
| sc-203956 | 896138-40-2 | C17H12N2O3 | 1 mg |
- Flt3 Inhibitor IV
A 3-aminoindazole compound that acts as a strong and ATP-competitive inhibitor of Flt3. It also exhibits excellent selectivity over KDR/VEGFR-2 and c-Kit.
| Catalog # | CAS Number | Molecular Formula | Unit |
|---|
| sc-221615 | N/A | C13H12N4 | 5 mg/25 mg |
- FPA 124
| Catalog # | CAS Number | Molecular Formula | Unit |
|---|
| sc-361179 | 902779-59-3 | C11H9Cl2CuN3O2S | 10 mg/50 mg |
- Genistin
Isoflavone glycoside found in soy-based foods. An inactive analog of the PTK inhibitor Genistein. Can be used as a negative control for Genistein. Reportedly reduces bone loss in ovarectomized rats.| Catalog # | CAS Number | Molecular Formula | Unit |
|---|
| sc-202168 | 529-59-9 | C21H20O10 | 5 mg |
- Gold sodium thiomalate
A gold(I) compound that inhibits the activity of IKK (ID50 = 10.9 µM) and disrupts PB1 (Phox and Bem1p) domain-mediated interactions between Par6 and PKCi (IC50 ~ 1 µM) by modifying cysteine residues within the catalytic domain of IKK and the PB1 domain of PKCi. Inhibits PKCi-dependent Rac1 activation in A549 cells.
| Catalog # | CAS Number | Molecular Formula | Unit |
|---|
| sc-203830 | 12244-57-4 | C4H4AuNaO4S | 50 mg |
- GSK 1059615
| Catalog # | CAS Number | Molecular Formula | Unit |
|---|
| sc-361198 | 958852-01-2 | C18H11N3O2S | 10 mg/50 mg |
- GSK 269962
| Catalog # | CAS Number | Molecular Formula | Unit |
|---|
| sc-363279 | 850664-21-0 | C29H30N8O5 | 10 mg/50 mg |
- GSK 429286
| Catalog # | CAS Number | Molecular Formula | Unit |
|---|
| sc-361200 | 864082-47-3 | C21H16F4N4O2 | 1 mg/10 mg |
- GSK 650394
| Catalog # | CAS Number | Molecular Formula | Unit |
|---|
| sc-361201 | 890842-28-1 | C25H22N2O2 | 10 mg/50 mg |
- GSK 690693
| Catalog # | CAS Number | Molecular Formula | Unit |
|---|
| sc-363280 | 937174-76-0 | C21H27N7O3 | 10 mg/50 mg |
- GTP 14564
A cell-permeable tricyclic benzofurano-indazolo compound which functions as a specific inhibitor of class III receptor tyrosine kinases.| Catalog # | CAS Number | Molecular Formula | Unit |
|---|
| sc-203062 | 34823-86-4 | C15H10N2O | 5 mg |
- GW441756 hydrochloride
A highly selective, potent TrkA kinase inhibitor which is orally active. IC50 = 2 nM.| Catalog # | CAS Number | Molecular Formula | Unit |
|---|
| sc-215121 | 504433-24-3 (non-salt) | C17H13N3O•HCl | 5 mg |
- GW4869
A cell permeable, selective inhibitor of N-SMase (neutral sphingomyelinase). This compound functions as an inhibitor, via a non-competitve manner.| Catalog # | CAS Number | Molecular Formula | Unit |
|---|
| sc-218578 | 6823-69-4 | C30H28N6O2•2HCl | 5 mg/25 mg |
- H-1152 . dihydrochloride
Cell permeable, highly specific, and potent ATP-competitive inhibitor of rho-kinase (ROCK) inhibitor.| Catalog # | CAS Number | Molecular Formula | Unit |
|---|
| sc-203592 | 451462-58-1 | C16H21N3O2S.2HCl | 1 mg/5 mg |
- H-1152 Dihydrochloride
A ROCK Inhibitor. A cell-permeable isoquinolinesulfonamide compoud that acts as a highly specific, potent, and ATP-competitive inhibitor of G-protein Rho-associated kinase (ROCK).| Catalog # | CAS Number | Molecular Formula | Unit |
|---|
| sc-207727 | 871543-07-6 | C16H23Cl2N3O2S | 2.5 mg |
- I-OMe-Tyrphostin AG 538
This product is an inhibitor of insulin growth factor 1 receptor protein tyrosine kinase.
| Catalog # | CAS Number | Molecular Formula | Unit |
|---|
| sc-300821 | N/A | C17H12INO5 | 5 mg |
- IKK-2 Inhibitor XI
| Catalog # | CAS Number | Molecular Formula | Unit |
|---|
| sc-359906 | N/A | C12H11N3O2S | 5 mg |
- IKK 16
Selective IκB kinase (IKK) inhibitor (IC50 values are 40, 70 and 200 nM for IKK-2, IKK complex and IKK-1 respectively). Inhibits TNF-α-stimulated IκB degradation and expression of adhesion molecules E-selectin, ICAM and VCAM (IC50 values are 1.0, 0.5, 0.3 and 0.3 μM respectively). In vivo, inhibits LPS-induced TNF-α release and neutrophil extravasion in thioglycollate-induced peritonitis.| Catalog # | CAS Number | Molecular Formula | Unit |
|---|
| sc-204009 | N/A | C28H29N5OS ·HCl | 10 mg/50 mg |
- IKK-2 Inhibitor VI
An ureido-thiophenecarboxamide compound acting as a potent inhibitor of IKK-2.| Catalog # | CAS Number | Molecular Formula | Unit |
|---|
| sc-221743 | N/A | C12H11N3O2S | 1 mg |
- IKK-3 Inhibitor IX
A thiophenecarbonitrile compound that acts as a potent ATP-competitive inhibitor of IKK-3. Have shown to be inactive against cytochrome P450 isozymes.| Catalog # | CAS Number | Molecular Formula | Unit |
|---|
| sc-221746 | N/A | C22H19N3O5S2 | 5 mg |
- Indirubin-3'-(2,3-dihydroxypropyl)oximether
c-Src inhibitor blocking downstream STAT3 signalling. Also, induces apoptosis in human cancer cells.| Catalog # | CAS Number | Molecular Formula | Unit |
|---|
| sc-221752 | N/A | C19H17N3O4 | 1 mg |
- Interleukin-1 Receptor-Associated-Kinase-1/4 Inhibitor
Benzimidazole compound that acts as a cell-permeable, potent selective inhibitor of IL-1 kinases. Shown to exhibit little activity against a panel of 27 other kinases, including, but not limited to, Ick and src.| Catalog # | CAS Number | Molecular Formula | Unit |
|---|
| sc-204013 | 509093-47-4 | C20H21N5O4 | 5 mg |
- IPA 3
A selective cell permeable Pak1 (group I p21-activated kinase) inhibitor which functions by inhibiting activators from binding to the active sites on the enzyme.| Catalog # | CAS Number | Molecular Formula | Unit |
|---|
| sc-204016 | 42521-82-4 | C20H14O2S2 | 5 mg/50 mg |
- JNK Inhibitor II, Negative Control
A useful negative control for JNK Inhibitor II. Inhibits JNK2 and JNK3 only at much higher concentrations.| Catalog # | CAS Number | Molecular Formula | Unit |
|---|
| sc-221781 | N/A | C15H10N2O | 1 mg |
- JNK Inhibitor IX
A thienylnaphthamide compound that acts as a selective and potent inhibitor of the ATP binding sites of JNK2 and JNK3. | Catalog # | CAS Number | Molecular Formula | Unit |
|---|
| sc-202671 | 312917-14-9 | C20H16N2OS | 5 mg |
- JNK Inhibitor V
Shown to be a nonpeptide ATP competitive inhibitor of JNK signal transduction pathway. Also reported to demonstrate anti-apoptotic capabilities. | Catalog # | CAS Number | Molecular Formula | Unit |
|---|
| sc-202672 | 345987-15-7 | C20H16N6S | 5 mg |
- JNK Inhibitor VIII
A JNK inhibitor that has been reported to suppress apoptosis, caspase cleavage, and cytochrome C release. Studies indicate that the inhibitor can block the phosphorylation of c-Jun and JNKAR1.| Catalog # | CAS Number | Molecular Formula | Unit |
|---|
| sc-202673 | 894804-07-0 | C18H20N4O4 | 5 mg |
- kb NB 142-70
kb NB 142-70 is a selective protein kinase D (PKD) inhibitor. Demonstrates a 7-fold increase in inhibition potency as an analog of CID 755673 (sc-205246).| Catalog # | CAS Number | Molecular Formula | Unit |
|---|
| sc-358834 | N/A | C11H9NO2S2 | 10 mg/50 mg |
- KH CB19
| Catalog # | CAS Number | Molecular Formula | Unit |
|---|
| sc-362756 | N/A | C15H13Cl2N3O2 | 1 mg |
- KI 8751
Cell-permeable quinolyloxyphenyl-urea compound that acts as a VEGFR-2-selective inhibitor. | Catalog # | CAS Number | Molecular Formula | Unit |
|---|
| sc-203090 | 228559-41-9 | C24H18F3N3O4 | 5 mg |
- KU 60019
| Catalog # | CAS Number | Molecular Formula | Unit |
|---|
| sc-363284 | 925701-46-8 | C30H33N3O5S | 10 mg/50 mg |
- L-779,450
Potent, ATP-competitive Raf kinase inhibitor (IC50 = 10 nM) that displays > 7, > 30 and > 70-fold selectivity over p38α, GSK3β and Lck respectively. Suppresses DNA synthesis and induces apoptosis in cells that proliferate in response to Raf-1 and A-Raf but not B-Raf.| Catalog # | CAS Number | Molecular Formula | Unit |
|---|
| sc-204046 | 303727-31-3 | C20H14ClN3O | 10 mg/50 mg |
- Lavendustin C methyl ester
| Catalog # | CAS Number | Molecular Formula | Unit |
|---|
| sc-221838 | N/A | C15H15NO5 | 1 mg/5 mg |
- LFM-A12
A potent and specific inhibitor of the EGFR tyrosine kinase in vitro (IC50 = 1.7 µM). Has been shown to kill over 99% of human breast cancer cells in vitro by triggering apoptosis. Even at high concentrations (175-350 µM), LFM-A12 does not affect the enzymatic activity of other PTKs including BTK, HCK, IRK, JAK1, JAK3, and Syk. | Catalog # | CAS Number | Molecular Formula | Unit |
|---|
| sc-295360 | N/A | C12H9F3N2O3 | 500 µg/1 mg |
- LFM-A13
A potent and selective inhibitor of Bruton's tyrosine kinase (BTK). Inhibits recombinant BTK with an IC50 value of 2.5 μM and has no activity on other protein kinases ( which include JAK1, JAK3, HCK, EGFR kinase and insulin receptor kinase) at concentrations of up to 278 μM.| Catalog # | CAS Number | Molecular Formula | Unit |
|---|
| sc-203623 | 62004-35-7 | C11H8Br2N2O2 | 10 mg/50 mg |
- Linoleoyl Ethanolamide-d4
Linoleoyl ethanolamide is an endocannabinoid detected in porcine brain and murine peritoneal macrophages which contains linoleate in place of the arachidonate moiety of arachidonoyl ethanolamide (AEA). It has weak affinity for the central cannabinoid (CB1) and peripheral cannabinoid (CB2) receptors, exhibiting Ki values of 10 µM and 25 µM, respectively. However, it is only approximately 4-fold less potent than AEA at causing catalepsy in mice (ED50 of 26. mg/kg). In addition, linoleoyl ethanolamide increases ERK phosphorylation and AP-1-dependent transcription approximately 1.-fold at 15 µM in a CB-receptor-independent manner. However, cellular toxicity is readily apparent at concentrations of 10-20 µM. Linoleoyl ethanolamide inhibits human fatty acid amide hydrolase-dependent hydrolysis of AEA with a Ki value of 9.0 µM, but also is hydrolyzed effectively by the enzyme.| Catalog # | CAS Number | Molecular Formula | Unit |
|---|
| sc-295362 | 68171-52-8 | C20H33D4NO2 | 100 µg/500 µg |
- LY 294002, 4′-NH2
A cell permeable 4′-amino derivative which inhibits the p110α, p110β, p110δ, and p110γ subunits of Phosphoinositide 3-kinase.| Catalog # | CAS Number | Molecular Formula | Unit |
|---|
| sc-203121 | 942289-87-4 | C19H18N2O3 | 5 mg/50 mg |
- LY 364947
A diheteroaryl-substituted pyrazole compound used as a selective, ATP-competitive inhibitor of TGF-β Receptor I kinase.| Catalog # | CAS Number | Molecular Formula | Unit |
|---|
| sc-203122 | 396129-53-6 | C17H12N4 | 5 mg/10 mg |
- LY-294,002 hydrochloride
| Catalog # | CAS Number | Molecular Formula | Unit |
|---|
| sc-215273 | 934389-88-5 | C19H18ClNO3 | 1 mg/5 mg |
- Met Kinase Inhibitor
| Catalog # | CAS Number | Molecular Formula | Unit |
|---|
| sc-204801 | 658084-23-2 | C28H30ClN5O4S | 1 mg |
- ML-7
Shown to be an inhibitor of Ca2+ dependent and independent smooth muscle myosin light chain kinases. Also, affects the osmotic volume regulation of cells via stimulation of K-CL cotransport.| Catalog # | CAS Number | Molecular Formula | Unit |
|---|
| sc-200557 | 110448-33-4 | C15H17IN2O2S··HCl | 10 mg/50 mg |
- MNS
A cell-permeable, cytotoxic β-nitrostyrene derivative which functions as a tyrosine kinase inhibitor that supresses human platelet aggregation.| Catalog # | CAS Number | Molecular Formula | Unit |
|---|
| sc-202229 | 1485-00-3 | C9H7NO4 | 50 mg |
- Myricetin
A non-ATP competitive MEK1 inhibitor and ATP-competitive inhibitor of CKI, CKII, IR, MLCK, PKA and PKC.| Catalog # | CAS Number | Molecular Formula | Unit |
|---|
| sc-203147 | 529-44-2 | C15H10O8 | 25 mg/100 mg |
- N-(2-Aminoethyl)-5-chloroisoquinoline-8-sulfonamide
Found to have a potent inhibitory action against casein kinase 1 completely with respect to ATP and a much weaker effect on casein kinase 2 and other protein kinases.| Catalog # | CAS Number | Molecular Formula | Unit |
|---|
| sc-207901 | 120615-25-0 | C11H12ClN3O2S | 10 mg |
- N-(4-Pyridyl)-N'-(2,4,6-trichlorophenyl)urea
Potent, selective, and ATP-competitive inhibitor of Rho kinase.| Catalog # | CAS Number | Molecular Formula | Unit |
|---|
| sc-221970 | 97627-27-5 | C12H8Cl3N3O | 5 mg |
- N-[2-(p-Cinnamylamino)ethyl]-5-isoquinolone Sulfonamide
Selective inhibitor of Protein Kinase A (cyclic AMP-dependeant Protein Kinase).| Catalog # | CAS Number | Molecular Formula | Unit |
|---|
| sc-207932 | 130964-40-8 | C20H21N3O2S | 10 mg |
- N-alpha-Benzoyl-L-argininamide hydrochloride
Shown to be a competitive inhibitor of urokinase and used as a substrate for cathepsin,| Catalog # | CAS Number | Molecular Formula | Unit |
|---|
| sc-301278 | 4299-03-0 | C13H19N5O2··HCl | 5 g/25 g |
- N-Boc-erythro-sphingosine
The N-Boc protected Sphingosine, a selective inhibitor of protein kinase C activity and phorbol dibutyrate binding in vitro in human platelets. It does not inhibit protein kinase A or myosin light chain kinase. It inhibits calmodulin-dependent enzymes.| Catalog # | CAS Number | Molecular Formula | Unit |
|---|
| sc-207996 | 609812-03-5 | C23H45NO4 | 25 mg |
- NFκB Activation Inhibitor VI, BOT-64
A cell-permeable benzoxathiole compound that acts as an IKK-2 inhibitor, by targeting the Ser177 and/or Ser181 residues in the kinase's activation loop domain.| Catalog # | CAS Number | Molecular Formula | Unit |
|---|
| sc-222062 | N/A | C15H15NO2S | 5 mg |
- NSC 33994
| Catalog # | CAS Number | Molecular Formula | Unit |
|---|
| sc-362774 | 82058-16-0 | C28H42N2O2 | 10 mg/50 mg |
- OM137
An inhibitor of aurora kinases. An aminothiazole derivative, which functions to override the spindle checkpoint primarily through inhibition of the Aurora kinases (mitotic kinases). A more potent inhibitor of Aurora B compared with Aurora A in vitro. The compound has some CDK1 inhibitory activity, but is likely that the major mode by which it drives mitotic exit of cells arrested in M phase via the spindle checkpoint is through its inhibitory activity against Aurora B kinase. | Catalog # | CAS Number | Molecular Formula | Unit |
|---|
| sc-255403 | 292170-13-9 | C13H14N4O3S | 5 mg |
- Palmitoyl-L-carnitine Chloride
Protein kinase inhibitor| Catalog # | CAS Number | Molecular Formula | Unit |
|---|
| sc-205789 | 18877-64-0 | C23H45NO4 ·HCl | 5 mg/10 mg |
- Pamidronate disodium salt hydrate
A bisphosphonate compound, which inhibits farnesyl diphosphate synthase and bone resorption. This compound stimulates polymorphonuclear leukocyte and platelet derived nitric oxide production.| Catalog # | CAS Number | Molecular Formula | Unit |
|---|
| sc-272006 | 57248-88-1 (anhydrous) | C3H9NO7P2Na2 ·H2O | 10 mg |
- PD 0325901
A potent MEK inhibitor that suppresses phosphorylation of ERK1/2 in murine colon 26 tumors with an IC50 value of 0.33 nM.| Catalog # | CAS Number | Molecular Formula | Unit |
|---|
| sc-205427 | 391210-10-9 | C16H14F3IN2O4 | 500 µg/1 mg |
- PD 161570
| Catalog # | CAS Number | Molecular Formula | Unit |
|---|
| sc-361284 | 192705-80-9 | C26H35Cl2N7O | 10 mg/50 mg |
- PD 407824
Selective inhibitor of checkpoint kinases Chk1 and Wee1 (IC50 values are 47 and 97 nM respectively). Displays selectivity over a range of other protein kinases; IC50 values are 3.4, 3.75, > 5, > 50, > 50 and > 50 μM for PKC, CDK4, other CDKs, c-Src, PDGFR and FGFR respectively.| Catalog # | CAS Number | Molecular Formula | Unit |
|---|
| sc-203660 | 622864-54-4 | C20H12N2O3 | 1 mg/10 mg |
- PF 04217903 mesylate
| Catalog # | CAS Number | Molecular Formula | Unit |
|---|
| sc-363286 | 956906-93-7 | C19H16N8O.CH3SO3H | 10 mg/50 mg |
- PF 431396
| Catalog # | CAS Number | Molecular Formula | Unit |
|---|
| sc-362780 | 717906-29-1 | C22H21F3N6O3S | 10 mg |
- PF 4708671
| Catalog # | CAS Number | Molecular Formula | Unit |
|---|
| sc-361288 | N/A | C19H21F3N6 | 10 mg/50 mg |
- PF 477736
| Catalog # | CAS Number | Molecular Formula | Unit |
|---|
| sc-362781 | 952021-60-2 | C22H25N7O2 | 10 mg/50 mg |
- PF 4800567 hydrochloride
| Catalog # | CAS Number | Molecular Formula | Unit |
|---|
| sc-362782 | 1188296-52-7 | C17H18ClN5O2.HCl | 10 mg/50 mg |
- PF 573228
A selective and potent focal adhesion kinase inhibitor that reportedly displays 50-250-fold selectivity for FAK over other protein kinases| Catalog # | CAS Number | Molecular Formula | Unit |
|---|
| sc-204179 | 869288-64-2 | C22H20F3N5O3S | 10 mg/50 mg |
- PF 670462
A selective casein kinase, CK1ε and CK1δ inhibitor which also shows potency against 42 other kinases.| Catalog # | CAS Number | Molecular Formula | Unit |
|---|
| sc-204180 | 950912-80-8 | C19H20FN5•2HCl | 10 mg/50 mg |
- PHA 665752
A small molecule, ATP competitive inhibitor of the catalytic activity of c-Met tyrosine kinase with apoptotic properties. | Catalog # | CAS Number | Molecular Formula | Unit |
|---|
| sc-203186 | 477575-56-7 | C32H34Cl2N4O4S | 2 mg |
- PI-103
A cell-permeable pyridinylfuranopyrimidine compound that acts as an ATP-competitive dual inhibitor of Class IA phosphatidylinositide 3-kinase and mTOR complex 1 and 2.| Catalog # | CAS Number | Molecular Formula | Unit |
|---|
| sc-203193 | 371935-74-9 | C19H16N4O3 | 1 mg/5 mg |
- PIM-1 Inhibitor 2
Potent Pim-1 kinase inhibitor (Ki = 91 nM).| Catalog # | CAS Number | Molecular Formula | Unit |
|---|
| sc-204194 | 477845-12-8 | C17H11CIN4O | 10 mg/50 mg |
- PKC-412
Reported to be an antiproliferatiive agent which inhibits protein kinase C. Additionally shown to increase endothelial nitric oxide (NO) synthase expression and NO production.| Catalog # | CAS Number | Molecular Formula | Unit |
|---|
| sc-200691 | 120685-11-2 | C35H30N4O4 | 1 mg/5 mg |
- PknG Inhibitor
A cell-permeable tetrahydrobenzothiophene compound that acts as a highly specific and ATP-binding site-targeting inhibitor against mycobacterial protein kinase G (PknG; IC50 = 390 nM), while exhibiting much reduced or no activity against 8 other mycobacterial and 25 other human kinases, including PKCα, the mammalian kinase most closely related to PknG. AX20017 is shown to completely inactivate PknG-mediated blockage of lysosomal transfer and degradation of M. bovis BCG in macrophages at concentrations (10µM or higher) that does not otherwise affect the growth of BCG outside its infected host.| Catalog # | CAS Number | Molecular Formula | Unit |
|---|
| sc-222180 | 329221-38-7 | C13H16N2O2S | 10 mg |
- PKR Inhibitor
The RNA-dependent protein kinase (PKR) inhibitor can inhibit RNA-induced PKR autophosphorylation and rescue PKR-dependent translation block. | Catalog # | CAS Number | Molecular Formula | Unit |
|---|
| sc-204200 | 608512-97-6 | C13H8N4OS | 5 mg |
- PKR Inhibitor, Negative Control
An oxindole compound that serves as a negative control for PKR Inhibitor. Shown to be inactive in inhibiting RNA-induced PKR autophosphorylation (IC50> 100 µM) or in rescuing PKR-dependent translation block. | Catalog # | CAS Number | Molecular Formula | Unit |
|---|
| sc-204201 | 852547-30-9 | C15H8Cl3NO2 | 10 mg |
- Polo-like Kinase Inhibitor III
Cell-permeable thiophene-benzimidazole compound that acts as a potent and reversible inhibitor against polo-like kinases.| Catalog # | CAS Number | Molecular Formula | Unit |
|---|
| sc-203202 | 660868-91-7 | C22H18F3N3O4S | 500 µg |
- PP 3
Negative control for the Src family protein tyrosine kinase inhibitor PP2. However, it inhibits the activity of EGFR kinase.| Catalog # | CAS Number | Molecular Formula | Unit |
|---|
| sc-203213 | 5334-30-5 | C11H9N5 | 1 mg |
- PP1 Analog II, 1NM-PP1
Cell-permeable PP1 analog that acts as a potent and selective inhibitor of mutant kinases over their wild-type progenitors.| Catalog # | CAS Number | Molecular Formula | Unit |
|---|
| sc-203214 | 221244-14-0 | C20H21N5 | 1 mg/5 mg |
- Protein Kinase Inhibitor, DMAP
Puromycin analog inhibits protein kinases. Inhibits TNF-α upregulation of ICAM-1, lipolysis, and the activation of JNK/SAPK.| Catalog # | CAS Number | Molecular Formula | Unit |
|---|
| sc-203220 | 938-55-6 | C7H9N5 | 50 mg |
- Pseudohypericin
A specific inhibitor of protein kinase C and D-β-H, an apoptosis inducer, and selective antagonist of corticotropin-releasing factor in murine models.| Catalog # | CAS Number | Molecular Formula | Unit |
|---|
| sc-202777 | 55954-61-5 | C30H16O9 | 1 mg/5 mg |
- psi-Tectorigenin
Shown to inhibit EGF-receptor Tyrosine Kinase leading to a block of phosphatidylinositol turnover.| Catalog # | CAS Number | Molecular Formula | Unit |
|---|
| sc-296865 | 13111-57-4 | C16H12O6 | 250 µg |
- Quercetagetin
A cell-permeable flavanol compound that acts a potent, ATP-competitive, and reversible inhibitor of PIM1 kinase.| Catalog # | CAS Number | Molecular Formula | Unit |
|---|
| sc-204221 | 90-18-6 | C15H10O8 | 5 mg |
- Quercetin Dihydrate
A ubiquitous natural flavonoid with antiproliferative properties. Inhibits PI 3-kinase, PI 4-kinase and PI-4-phosphate 5-kinase, and reduces IP3 levels, blocking oncogenic signaling. Induces apoptosis of cells in G1 and S.| Catalog # | CAS Number | Molecular Formula | Unit |
|---|
| sc-203225 | 6151-25-3 | C15H10O7 ·2H2O | 5 g/25 g |
- rac-3-Octadecanamido-2-Methoxypropan-1-ol Phosphocholine
Shows strong inhibitory action against neoplastic cell growth in vitro. Inhibits Protein Kinase C.| Catalog # | CAS Number | Molecular Formula | Unit |
|---|
| sc-208288 | 163702-19-0 | C27H57O6N2P•1.5H2O | 10 mg |
- Raf Kinase Inhibitor IV
Cell-permeable triarylimidazole compound that acts as a reversible, ATP-competitive, and highly potent inhibitor of Raf kinase.| Catalog # | CAS Number | Molecular Formula | Unit |
|---|
| sc-203233 | 303727-31-3 | C20H14ClN3O•xH2O | 1 mg |
- Raf Kinase Inhibitor V
A cell-permeable azaindole compound that acts as a potent, ATP-site targeting and reversible inhibitor of Raf kinase with excellent selectivity over 64-other kinases. Shown to block ERK phosphorylation, induce cell cycle arrest and apoptosis in several B-RafV600E melanoma cells.| Catalog # | CAS Number | Molecular Formula | Unit |
|---|
| sc-222241 | N/A | C17H14ClF2N3O3S | 1 mg |
- Rho Kinase Inhibitor III, Rockout
A cell permeable ATP-competitive Rho Kinase inhibitor observed to inhibit the blebbing and promote cell spreading.| Catalog # | CAS Number | Molecular Formula | Unit |
|---|
| sc-203237 | 7272-84-6 | C13H10N2 | 5 mg |
- Rho Kinase Inhibitor IV
A glycyl analog of Rho-Kinase Inhibitor which inhibits ROCK with an improved selectivity at 6 nM.| Catalog # | CAS Number | Molecular Formula | Unit |
|---|
| sc-222254 | 913844-45-8 | C18H24N4O3S•2HCl | 1 mg |
- Rho Kinase Inhibitor V
A cell-permeable pyrazolyl carboxamide compound that acts as a potent, ATP-binding pocket-targeting inhibitor of ROCK-II and effectively inhibits the myosin light chain 2 phosphorylation on Thr18/Ser19 in A7r5 cells. It affects the activities of PKA, MRCK, Akt1 and CYP-450 enzymes only at much higher concentrations. | Catalog # | CAS Number | Molecular Formula | Unit |
|---|
| sc-222255 | 1072906-02-5 | C18H15N3O3 | 5 mg |
- Ro-31-8220 in solution
| Catalog # | CAS Number | Molecular Formula | Unit |
|---|
| sc-358721 | 138489-18-6 | C25H23N5O2S ·CH3SO3H | 1 mg |
- Rottlerin
Inhibitor of CaM kinase III, PKC δ, PKC α, PKC β, PKC ε, PKC η and PKC ζ, but with significantly reduced potency; also a hERG activator.| Catalog # | CAS Number | Molecular Formula | Unit |
|---|
| sc-3550 | 82-08-6 | C30H28O8 | 10 mg |
- Rp-8-CPT-cAMPS
Lipophilic analog of the competitive inhibitor of protein kinase A (cyclic AMP antagonist). | Catalog # | CAS Number | Molecular Formula | Unit |
|---|
| sc-215821 | 129735-01-9 | C16H14ClN5O5PS2 ·Na | 5 µmol |
- RPI-1
A competitive, potent ATP-dependent Ret kinase inhibitor. The compound also inhibits c-Met. Increased tumorigenicity, motility, and invasiveness have been described as biological consequences of HGF/Met deregulation in tumor cells, thus not surprisingly RPI-1 treatment of H460 cells resulted in a strong reduction of both colony number and size. The compound is also active at mouse NSCLC H460 xenograft tumor and metastasis model. Mechanistically RPI-1 inhibits Met phosphorylation at Tyr1234/Tyr1235, known to activate the intrinsic kinase activity.| Catalog # | CAS Number | Molecular Formula | Unit |
|---|
| sc-255524 | 269730-03-2 | C17H15NO4 | 5 mg |
- SB 590885
| Catalog # | CAS Number | Molecular Formula | Unit |
|---|
| sc-363287 | 405554-55-4 | C27H27N5O2 | 10 mg/50 mg |
- SBE 13 hydrochloride
| Catalog # | CAS Number | Molecular Formula | Unit |
|---|
| sc-362795 | 1052532-15-6 | C24H27ClN2O4.HCl | 10 mg/50 mg |
- SC-514
A selective and reversible inhibitor of IκB kinase 2 (IKK2); displays greater than 10-fold selectivity over 28 other kinases, including JNK, p38, MK2, and ERK.| Catalog # | CAS Number | Molecular Formula | Unit |
|---|
| sc-205504 | 354812-17-2 | C9H8N2OS2 | 5 mg/10 mg |
- Scytonemin
An indolic-phenolic pigment and a photo-stable UV shield in prokaryotes. Also found to be an inhibitor of polo-like kinases.| Catalog # | CAS Number | Molecular Formula | Unit |
|---|
| sc-202337 | 152075-98-4 | C36H20N2O4 | 1 mg |
- SD 1008
JAK2/STAT3 signaling pathway inhibitor which additionally inhibits Src.| Catalog # | CAS Number | Molecular Formula | Unit |
|---|
| sc-358791 | 960201-81-4 | C18H19NO5 | 10 mg/50 mg |
- SH-5
Inhibitor of Akt (PKB) activation without affecting activation of the upstream kinase PDK-1, or other kinases downstream of Ras such as MAPK. Induces apoptosis and kills a variety of cancer cell lines containing high levels of active Akt and depending upon Akt for survival.| Catalog # | CAS Number | Molecular Formula | Unit |
|---|
| sc-205973 | N/A | C29H59O10P | 0.5 mg/1 mg |
- SH-6
Inhibitor of Akt (PKB) activation without affecting activation of the upstream kinase PDK-1, or other kinases downstream of Ras (such as MAPK). Induces apoptosis and kills a variety of cancer cell lines containing high levels of active Akt and depending upon Akt for survival.| Catalog # | CAS Number | Molecular Formula | Unit |
|---|
| sc-205974 | N/A | C28H57O9P | 0.5 mg/1 mg |
- SKI II
Selective non-lipid inhibitor of sphingosine kinase (IC50 = 0.5 μM); does not act at ATP-binding site. Displays no inhibition of ERK2, PI 3-kinase, or PKCα at concentrations up to 60 μM. Reduces levels of sphingosine-1-phosphate in MDA-MB-231 breast cancer cells. Induces apoptosis and inhibits proliferation in several other tumor cell lines in vitro (IC50 = 0.9-4.6 μM).
| Catalog # | CAS Number | Molecular Formula | Unit |
|---|
| sc-204286 | 312636-16-1 | C15H11ClN2OS | 10 mg/50 mg |
- SL 0101-1
A selective kinase inhibitor shown to inhibit p90 ribosomal S6 kinase, without inhibiting upstream kinases such as Raf, MEK and PKC.| Catalog # | CAS Number | Molecular Formula | Unit |
|---|
| sc-204287 | 77307-50-7 | C25H24O12 | 1 mg |
- Smad3 Inhibitor, SIS3
A cell-permeable pyrrolopyridine compound that selectively inhibits TGF-β1-dependent Smad3 phosphorylation and Smad3-mediated cellular signaling with no effect on Smad2, p38 MAPK, ERK, or PI 3-K signaling. | Catalog # | CAS Number | Molecular Formula | Unit |
|---|
| sc-222318 | 1009104-85-1 | C28H27N3O3 | 1 mg |
- SP600125
Potent, selective and reversible inhibitor of JNK1,-2, and -3. An ATP competitive inhibitor with >20 fold selectivity versus a range of similar kinases.| Catalog # | CAS Number | Molecular Formula | Unit |
|---|
| sc-200635 | 129-56-6 | C14H8N2O | 10 mg/50 mg |
- SR 3677 hydrochloride
| Catalog # | CAS Number | Molecular Formula | Unit |
|---|
| sc-361364 | 1072959-67-1 | C22H24N4O4.HCl | 10 mg/50 mg |
- ST638
Protein tyrosine kinase inhibitor that also inhibits HGF-induced MAP kinase activation in hepatocytes. Inhibits phospholipase D activity in human neutrophils.| Catalog # | CAS Number | Molecular Formula | Unit |
|---|
| sc-202344 | 107761-24-0 | C19H18N2O3S | 5 mg |
- Staurosporine
| Catalog # | CAS Number | Molecular Formula | Unit |
|---|
| sc-360258 | 62996-74-1 | C28H26N4O3 | 100 µl |
- STO-609
A selective ATP-competitive Ca2+/calmodulin-dependent protein kinase inhibitor.| Catalog # | CAS Number | Molecular Formula | Unit |
|---|
| sc-202820 | 52029-86-4 | C19H10N2O3 ·CH3CO2H | 5 mg |
- SU 3327
A selective inhibitor of c-Jun N-terminal kinase (JNK) (IC50 = 0.7 μM). Shown to inhibit the protein-protein interaction between JNK and JIP (IC50 = 239 nM). Displays selectivity over p38 MAPK and Akt and restores insulin sensitivity in a mouse model of type-2 diabetes. | Catalog # | CAS Number | Molecular Formula | Unit |
|---|
| sc-296430 | 40045-50-9 | C5H3N5O2S3 | 10 mg/50 mg |
- SU 4312
SU 4312 is a selective and potent vascular endothelial cell growth factor receptor (VEGFR) inhibitor.| Catalog # | CAS Number | Molecular Formula | Unit |
|---|
| sc-200637 | 5812-07-7 | C17H16N2O | 5 mg/25 mg |
- SU 4984
Inhibitor of tyrosine kinase activity of fibroblast growth factor receptor 1 (FGFR1). Inhibits αFGF-induced tyrosine phosphorylation of ERK1 and ERK2 and the tyrosine phosphorylation of the PDGF receptor and the insulin receptor. Does not inhibit the kinase activity of the EGF receptor.| Catalog # | CAS Number | Molecular Formula | Unit |
|---|
| sc-205977 | 186610-89-9 | C20H19N3O2 | 1 mg |
- SU 5402
A FGFR-specific tyrosine kinase inhibitor. Research shows that inhibition of FGFR results in the blocking of NVPs secretion and an increase of Ca2+. | Catalog # | CAS Number | Molecular Formula | Unit |
|---|
| sc-204308 | 215543-92-3 | C17H16N2O3 | 1 mg/5 mg |
- SU1498
Demonstrates reversible, potent ATP-competitive and selective inhibitor of Flk-1 kinase, a vascular endothelial growth factor (VEGF) receptor kinase. Able to reduce expression of ets-1, a transcription factor stimulated by VEGF. Can potentially act as an angiogenesis inhibitor, as well.| Catalog # | CAS Number | Molecular Formula | Unit |
|---|
| sc-355982 | N/A | C25H30N2O2 | 5 mg |
- SU6656
A potent, selective Src family kinase inhibitor known to inhibit c-Src, Fyn, c-Yes, Lyn, Lck and PDGF receptor kinase.| Catalog # | CAS Number | Molecular Formula | Unit |
|---|
| sc-203286 | 330161-87-0 | C19H21N3O3S | 1 mg |
- SX 011
A selective p38α, p38β and JNK-2 inhibitor.| Catalog # | CAS Number | Molecular Formula | Unit |
|---|
| sc-358841 | 309913-42-6 | C26H27ClFN3O3 | 10 mg |
- Syk Inhibitor IV, BAY 61-3606
Cell-permeable imidazopyrimidine. Potent, ATP-competitive, reversible, and highly selective inhibitor of Syk and Syk-mediated cellular functions.| Catalog # | CAS Number | Molecular Formula | Unit |
|---|
| sc-202351 | 732983-37-8 | C20H21ClN6O4 | 2 mg |
- TAK 715
| Catalog # | CAS Number | Molecular Formula | Unit |
|---|
| sc-362799 | 303162-79-0 | C24H21N3OS | 10 mg/50 mg |
- (+/-)-Taxifolin hydrate
An antioxidant flavenoid.| Catalog # | CAS Number | Molecular Formula | Unit |
|---|
| sc-258192 | 24198-97-8 | C15H12O7 ·xH2O | 25 mg |
- TC-A 2317 hydrochloride
| Catalog # | CAS Number | Molecular Formula | Unit |
|---|
| sc-363291 | 1245907-03-2 | C19H28N6O.HCl | 10 mg/50 mg |
- TCS 2002
| Catalog # | CAS Number | Molecular Formula | Unit |
|---|
| sc-359020 | 1005201-24-0 | C18H14N2O3S | 10 mg/50 mg |
- TCS 21311
| Catalog # | CAS Number | Molecular Formula | Unit |
|---|
| sc-362804 | 1260181-14-3 | C27H25F3N4O4 | 10 mg/50 mg |
- TCS 2312 dihydrochloride
Potent and selective checkpoint kinase 1 (chk1) inhibitor (Ki = 0.38 nM, EC50 = 60 nM). Enhances the cell killing activity of Gemcitabine in breast and prostate cancer cell lines. Displays antiproliferative effects in vitro.| Catalog # | CAS Number | Molecular Formula | Unit |
|---|
| sc-204326 | 838823-32-8 | C25H24N4O2.2HCl | 1 mg |
- TCS PIM-1 1
ATP-competitive Pim-1 kinase inhibitor that displays selectivity over Pim-2 and MEK1/2 (IC50 values are 50, > 20000 and > 20000 nM for Pim-1, Pim-2 and MEK1/2 respectively).| Catalog # | CAS Number | Molecular Formula | Unit |
|---|
| sc-204330 | N/A | C18H11BrN2O2 | 10 mg/50 mg |
- TCS PIM-1 4a
A selective, ATP-competitive Pim kinase inhibitor (IC50 values are 24 and 100 nM for Pim-1 and Pim-2 respectively). Shown to display selectivity over a panel of ~50 other kinases tested. Also exhibits cytotoxicity in PC3 prostate carcinoma cells in vitro (IC50 = 17 μM). | Catalog # | CAS Number | Molecular Formula | Unit |
|---|
| sc-296450 | 438190-29-5 | C11H6F3NO2S | 10 mg/50 mg |
- Terreic Acid
Terreic acid is a metabolite that displays antibiotic properties. It has been found to inhibit the catalytic activity of BTK.| Catalog # | CAS Number | Molecular Formula | Unit |
|---|
| sc-200655 | 121-40-4 | C7H6O4 | 1 mg/5 mg |
- TG 003
| Catalog # | CAS Number | Molecular Formula | Unit |
|---|
| sc-362808 | 719277-26-6 | C13H15NO2S | 10 mg/50 mg |
- TGF-β RI Kinase Inhibitor III
A cell-permeable imidazolyl-pyridine compound that acts as a potent, ATP-competitive, reversible, and selective inhibitor of activin receptor-like kinase 4 (IC50 = 129 nM), 5 ( IC50 = 47 nM), and 7. It inhibits p38 MAPKα only at much higher concentrations (IC50 = 10.6 µM) and has little effect against ALK1/2/3/6 as well as a panel of 26 other kinases. | Catalog # | CAS Number | Molecular Formula | Unit |
|---|
| sc-204341 | 356559-13-2 | C20H21N3O2 ·HCl | 2 mg |
- TGF-β RI Kinase Inhibitor V
A selective and reversible inhibitor, which suppresses TGF-β RI/ALK5 signaling.| Catalog # | CAS Number | Molecular Formula | Unit |
|---|
| sc-203294 | 627536-09-8 | C17H10ClFN6 | 2 mg |
- TGF-β RI Kinase Inhibitor VIII
Cell-permeable quinoxaline compound that is an ATP-competitive inhibitor against type I TGF-βreceptor TbR-I/ALK5.| Catalog # | CAS Number | Molecular Formula | Unit |
|---|
| sc-203295 | 356559-20-1 | C21H21N5 | 2 mg |
- TMCB
| Catalog # | CAS Number | Molecular Formula | Unit |
|---|
| sc-361383 | 905105-89-7 | C11H9Br4N3O2 | 10 mg/50 mg |
- Torin 2
| Catalog # | CAS Number | Molecular Formula | Unit |
|---|
| sc-362811 | 1223001-51-1 | C24H15F3N4O | 10 mg/50 mg |
- Tozasertib
| Catalog # | CAS Number | Molecular Formula | Unit |
|---|
| sc-358750 | 639089-54-6 | C23H28N8OS | 25 mg/50 mg |
- Tpl2 Kinase Inhibitor
Tpl2 Kinase Inhibitor is a reversible naphthyridine ATP-competitive inhibitor of the enzyme Tpl2 kinase. The enzyme is a hematopoietically expressed serine-threonine kinase responsible for regulating tumor necrosis factor-α, toll-like receptor, and G protein–coupled receptor signaling.| Catalog # | CAS Number | Molecular Formula | Unit |
|---|
| sc-204351 | 871307-18-5 | C21H14ClFN6 | 1 mg |
- Triciribine
Known to suppress the phosphorylation level and kinase activity of Akt. Selectively inhibits Akt1, -2, and -3 without inhibiting known upstream activators, PDK1 and PI 3-Kinase, of Akt. | Catalog # | CAS Number | Molecular Formula | Unit |
|---|
| sc-200661 | 35943-35-2 | C13H16N6O4 | 1 mg/5 mg |
- TX-1123
May be useful as a therapeutic agent for cancer treatment in animal models. A cell-permeable, reversible and substrate-competitive arylidene-cyclopentenedione derived tyrphostin that acts as a kinase inhibitor for Src, eEF2-K, and PKA (IC50 = 2.2, 3.2, and 9.6 µM, respectively). Has been shown to inhibits EGFR-K and PKC, but only at much higher concentrations (IC50 = 320 µM). Reported to exhibit potent anti-tumor activity (EC50 = 3.66 and 39 µM in HepG2 and HCT116 tumor cells, respectively) with greatly reduced mitochondrial- (≥1000-fold) and hepato-toxicity (≥50-fold) when compared with another tyrphostin, AG 17 (sc-200568 and sc-200568A).| Catalog # | CAS Number | Molecular Formula | Unit |
|---|
| sc-296675 | 157397-06-3 | C20H24O3 | 10 mg |
- TWS 119 ditrifluoroacetate
| Catalog # | CAS Number | Molecular Formula | Unit |
|---|
| sc-358727 | 601514-19-6 (non-salt) | C18H14N4O2•2CF3CO2H | 10 mg |
- TX-1918
May be useful as a therapeutic agent for cancer treatment in animal models. A cell-permeable arylidene-cyclopentenedione derived tyrphostin that acts as a potent inhibitor for eEF2-K (IC50 = 440 nM). Has been shown to inhibit other kinases at much higher concentrations (IC50 = 4.4, 44, 44, and 440 µM for Src, PKA, PKC, and EGFR-K, respectively). Reported to exhibit potent anti-tumor activity (EC50 = 2.07 and 230 µM in HepG2 and HCT116 tumor cells, respectively) with greatly reduced mitochondrial- (≥5000-fold) and hepato-toxicity (≥90-fold) when compared with another tyrphostin, AG 17 (sc-200568 and sc-200568).| Catalog # | CAS Number | Molecular Formula | Unit |
|---|
| sc-296676 | N/A | C14H12O3 | 10 mg |
- Tyrene CR4
Cell-permeable, reversible, and substrate competitive hydroxystryrylacrylonitrile tyrosine kinase inhibitor that show anti-tumor properties. Potently inhibits the kinase activities of JAK2 and Bcr-Abl (IC50 ~100-600 nM and 500-700 nM, respectively). Displays excellent selectivity over other tyrosine kinases, Btk, Lck, Lyn, Src, Syk and ZAP-70 (IC50 >5 µM). Has been shown to preferentially induce apoptosis in acute lymphoblastic (ALL) and myeloid leukemia cells (AML), while exhibiting little deleterious effect towards normal bone marrow cell differentiation and proliferation. Has been reported to be more potent than AG 490 (sc-202046) in inducing ALL cells growth arrest (IC50 ~ 120 nM vs. 5-25 µM). Its in vivo efficacy in cancer reduction has been successfully demonstrated in NOD-SCID mice engrafted with human Ph+ ALL cells.| Catalog # | CAS Number | Molecular Formula | Unit |
|---|
| sc-296677 | N/A | C19H16N2O3 | 5 mg |
- Tyrphostin 9 (RG-50872, Malonaben, SF 6847)
Reported to be tyrosine kinase protein inhibitor and potent reversible inhibitor of PDGF-induced mitogenesis.Also reported to inhibit actin ring formation and bone resorption in murine osteoclasts. | Catalog # | CAS Number | Molecular Formula | Unit |
|---|
| sc-200568 | 10537-47-0 | C18H22N2O | 50 mg/250 mg |
- Tyrphostin AG 1433
A specific and potent inhibitor of PDGF-β receptor kinase (IC50 = 5.0 µM) and of KDR/Flk-1/VEGF Receptor 2 (IC50 = 9.3 µM). Also acts as angiogenesis inhibitor.| Catalog # | CAS Number | Molecular Formula | Unit |
|---|
| sc-205984 | 168836-03-1 | C16H14N2O2 | 1 mg/5 mg |
- Tyrphostin B42
A potent inhibitor of the JAK-2 tyrosine kinase that preferentially inhibits JAK-2 over other kinases.| Catalog # | CAS Number | Molecular Formula | Unit |
|---|
| sc-3556 | 133550-30-8 | C17H14N2O3 | 5 mg |
- U0124
Inactive analog of U0126. Used as a negative control. Doesn’t inhibit MEK at concentrations up to 100 μM.| Catalog # | CAS Number | Molecular Formula | Unit |
|---|
| sc-204934 | 108923-79-1 | C8H10N4S2 | 10 mg |
- UCN-01
A Staurosporine (sc-3510) analogue that acts as a selective inhibitor of protein kinase C, potently inhibits MK2, induces UCN-01 G1 phase accumulation, dephosphorylates Rb and CDK2 proteins, and induces CDK inhibitor p21/Cip1/WAF1/Sdi1.| Catalog # | CAS Number | Molecular Formula | Unit |
|---|
| sc-202376 | 112953-11-4 | C28H26N4O4 | 500 µg |
- UCN-02
Indolocarbazole isolated as a minor co-metabolite of high producing staurosporine strains of selected actinomycetes. Less selective than isomer UCN-01, UCN-02 exhibits comparable activity.| Catalog # | CAS Number | Molecular Formula | Unit |
|---|
| sc-202377 | 121569-61-7 | C28H26N4O4 | 500 µg |
- VEGF Inducer, GS4012
This is a cell-permeable pyridinyl-thioether compound which acts as a potent inducer of VEGF and VEGF-mediated vessel formation. GS4012-induced upregulation of VEGF correlates well with its ability to suppress the gridlock/coarctation phenotype (7.5 µg/ml) in Zebrafish as well as to stimulate tubule network formation (5 µg/ml) in HUVECs.| Catalog # | CAS Number | Molecular Formula | Unit |
|---|
| sc-222411 | N/A | C14H15NOS ·HCl | 10 mg |
- VX 702
| Catalog # | CAS Number | Molecular Formula | Unit |
|---|
| sc-361400 | 479543-46-9 | C19H12F4N4O2•xH2O | 10 mg |
- W-12, Hydrochloride
Calmodulin antagonist that inhibits myosin light chain kinase and Ca2+-calmodulin-dependent phosphodiesterase.| Catalog # | CAS Number | Molecular Formula | Unit |
|---|
| sc-203309 | 89108-46-3 | C14H18N2O2S ·HCl | 1 mg |
- XMD 8-92
| Catalog # | CAS Number | Molecular Formula | Unit |
|---|
| sc-361408 | 1234480-50-2 (free base) | C26H30N6O3 ·C2HF3O2 | 10 mg/50 mg |
- Y-27632 dihydrochloride monohydrate
A potent, cell-permeable, ROCK (Rho-associated coiled coil forming protein serine/threonine kinase) inhibitor, that has also been shown to, ATP-competively, inhibit ROCK-II.| Catalog # | CAS Number | Molecular Formula | Unit |
|---|
| sc-216067 | 331752-47-7 | C14H21N3O ·2HCl ·H2O | 1 mg/5 mg |
- ZM 323881 hydrochloride
A potent and selective inhibitor of human vascular endothelial growth factor receptor 2 (VEGFR-2/KDR) activity. Inhibits VEGF-A-induced endothelial cell proliferation in vitro (IC50 = 8 nM). Selectively inhibits VEGFR-2 (IC50 = 2 nM) over VEGFR-1 and a range of other receptor tyrosine kinases such as PDGFRβ, FGFR1, EGFR and erbB2 (IC50 > 50 μM).| Catalog # | CAS Number | Molecular Formula | Unit |
|---|
| sc-296861 | 324077-30-7 | C22H18FN3O2•HCl | 1 mg/10 mg |
- ZM 336372
A reversible tyrosine kinase modulator selectively inhibiting protein kinase c-Raf.| Catalog # | CAS Number | Molecular Formula | Unit |
|---|
| sc-202857 | 208260-29-1 | C23H23N3O3 | 1 mg |
- ZM-306416
VEGF receptor tyrosine kinase inhibitor. Inhibits KDR (IC50= 100nM ) and Flt (IC50= 2µM) tyrosine kinases .| Catalog # | CAS Number | Molecular Formula | Unit |
|---|
| sc-200676 | 690206-97-4 | C16H13ClFN3O2 | 1 mg/10 mg |
|